Vertical Aerospace Welcomes UK Funding Boost for Next-Generation Aviation Technology

Vertical Aerospace Welcomes UK Funding Boost for Next-Generation Aviation Technology

Vertical’s piloted VX4 prototype during recent flight testing LONDON & NEW YORK, September 29, 2025–(BUSINESS WIRE)–Vertical Aerospace (Vertical) [NYSE: EVTL], a global aerospace and technology company that is pioneering electric aviation, today welcomes the UK Department for Transport’s announcement that funding has been awarded to projects working on next-generation zero-emission aircraft and the development of…

Read More
NKGen Biotech to Present on the Use of Troculeucel for Neurodegenerative Diseases at the 3rd China Great Bay Cell and Gene Therapy Forum

NKGen Biotech to Present on the Use of Troculeucel for Neurodegenerative Diseases at the 3rd China Great Bay Cell and Gene Therapy Forum

NKGen Biotech, Inc. SANTA ANA, Calif., Sept. 18, 2025 (GLOBE NEWSWIRE) — NKGen Biotech, Inc. (OTC: NKGN) (“NKGen” or the “Company”), a clinical-stage biotechnology company focused on the development and commercialization of innovative autologous and allogeneic natural killer (“NK”) cell therapeutics, today announced that Paul Y. Song, M.D., Chairman and Chief Executive Officer of NKGen,…

Read More